Variantyx Combines Long Nanopore, Short Illumina Reads for Rare Disease Whole-Genome Diagnostic Test
Premium
The firm recently launched the Genomic Unity 2.0 assay, which it claims is the first commercial diagnostic rare disease test to include nanopore sequencing.
The new MiSeq i100 line can sequence up to 30 Gb per run in a matter of hours, rather than days, and offers the ability to store reagents at room temperature.
Pacific Biosciences, National Cancer Center of Singapore to Sequence Cancers Prevalent in Asia
The project will profile various cancer types using PacBio's Onso short-read sequencing system and Revio platform using the Kinnex long-read single-cell sequencing kit.
23andMe to Undertake 1-for-20 Reverse Stock Split
The reverse stock split will reduce the number of the company's issued and outstanding common shares to about 25.8 million from nearly 517 million.
10x Genomics' Share Price Tumbles as Preliminary Q3 Revenues Show 1 Percent Drop
For the three months ended Sept. 30, 10x Genomics reported $151.7 million in total revenue, with lower instrument revenues partially offset by higher consumables revenues.